title: Cardioprotective effects of ω -3 PUFAs in chronic kidney disease.
abstract: The prevalence rate of chronic kidney disease (CKD) is increasing worldwide, and cardiovascular disease (CVD) is a main cause of death in patients with CKD. The high incidence of CVD in CKD patients is related to chronic inflammation, dyslipidemia, malnutrition, atherosclerosis, and vascular calcification. Omega-3 polyunsaturated fatty acids ( ω -3 PUFAs) have been shown to reduce the risk of CVD. In this paper, we review the beneficial effects of ω -3 PUFAs on CVD and the possible cardioprotective mechanisms of ω -3 PUFAs in CKD patients by determining the effect of ω -3 PUFAs in the general population. ω -3 PUFAs have several cardioprotective benefits, such as reducing inflammation, decreasing oxidative stress, inhibiting platelet activity, exerting antiarrhythmic effects, and improving triglyceride levels, in the general population and patients with CKD. Modifications of erythrocyte membrane fatty acid content, including an increased ω -3 index and decreased oleic acid, after ω -3 PUFAs supplementation are important changes related to CVD risk reduction in the general population and patients with CKD. Further basic and clinical studies are essential to confirm the effects of ω -3 PUFAs on vitamin D activation, vascular calcification prevention, cardiovascular events, and mortality in CKD patients.
authors: Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul 110-744, Republic of Korea.
authors: Su Mi
authors: SM
authors: Lee
authors: Won Suk
authors: WS
authors: An
mesh_terms: D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000401:mortality; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism; D015525:Fatty Acids, Omega-3 / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
chemical_list: D002316:Cardiotonic Agents; D015525:Fatty Acids, Omega-3
references: Science. 2001 Aug 3;293(5531):801-4
references: 11496904
references: Circulation. 2003 Jul 15;108(2):155-60
references: 12821543
references: N Engl J Med. 2010 Nov 18;363(21):2015-26
references: 20929341
references: J Hypertens. 2013 Jan;31(1):160-8
references: 23183279
references: Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S112-9
references: 9820470
references: Prev Med. 2004 Jul;39(1):212-20
references: 15208005
references: Curr Opin Lipidol. 2006 Aug;17(4):387-93
references: 16832161
references: J Clin Invest. 2002 Jul;110(2):229-38
references: 12122115
references: Ann Med. 2009;41(4):301-10
references: 19148838
references: Prostaglandins Leukot Essent Fatty Acids. 2012 Jan-Feb;86(1-2):29-34
references: 22071008
references: In Vivo. 2006 Mar-Apr;20(2):307-10
references: 16634535
references: Lipids. 2001;36 Suppl:S107-10
references: 11837982
references: Hypertension. 2003 Nov;42(5):1050-65
references: 14604997
references: Clin J Am Soc Nephrol. 2006 Mar;1(2):182-92
references: 17699207
references: Annu Rev Nutr. 2005;25:317-40
references: 16011470
references: Ann Epidemiol. 2009 Jul;19(7):468-83
references: 19523595
references: Am J Cardiol. 2006 Apr 15;97(8):1127-30
references: 16616012
references: J Ren Nutr. 2012 Jan;22(1):58-66
references: 21620727
references: Arch Intern Med. 2008 Aug 11;168(15):1629-37
references: 18695076
references: J Biol Chem. 2002 May 31;277(22):19991-7
references: 11901155
references: Circulation. 2007 Jul 3;116(1):85-97
references: 17606856
references: N Engl J Med. 2004 Sep 23;351(13):1296-305
references: 15385656
references: Circulation. 2004 Sep 21;110(12):1645-9
references: 15353491
references: J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):387-92
references: 15225806
references: Am J Clin Nutr. 1995 Jun;61(6 Suppl):1368S-1373S
references: 7754989
references: J Hypertens. 2009 Sep;27(9):1863-72
references: 19705518
references: Clin Nephrol. 1998 Feb;49(2):102-6
references: 9524780
references: J Am Diet Assoc. 2009 Apr;109(4):668-79
references: 19328262
references: Front Physiol. 2012 Oct 30;3:416
references: 23115552
references: J Am Coll Cardiol. 2008 Jun 24;51(25):2375-84
references: 18565393
references: Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1119-23
references: 9672072
references: Atherosclerosis. 2011 Mar;215(1):43-51
references: 21193197
references: Int J Cardiol. 2001 Mar;78(1):27-32
references: 11259810
references: JAMA. 2012 Sep 12;308(10):1024-33
references: 22968891
references: J Nutr. 2008 Feb;138(2):287-91
references: 18203893
references: Diabetes Care. 2010 Jun;33(6):1379-81
references: 20215450
references: J Clin Invest. 1987 Jun;79(6):1659-64
references: 2884234
references: Clin J Am Soc Nephrol. 2009 Sep;4(9):1515-22
references: 19696220
references: Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun;60(5-6):411-20
references: 10471131
references: J Ren Nutr. 2009 Jul;19(4):267-74
references: 19539181
references: J Am Soc Nephrol. 2001 Jul;12(7):1549-1557
references: 11423586
references: Nephrology (Carlton). 2007 Aug;12(4):331-6
references: 17635746
references: BMC Cancer. 2010 Jul 02;10:347
references: 20594355
references: J Am Soc Nephrol. 2009 Jul;20(7):1453-64
references: 19478096
references: Prostaglandins Leukot Essent Fatty Acids. 1997 Oct;57(4-5):419-21
references: 9430389
references: Am Heart J. 2008 Dec;156(6):1117-23
references: 19033007
references: N Engl J Med. 2007 Jul 19;357(3):266-81
references: 17634462
references: Am J Physiol Renal Physiol. 2009 Oct;297(4):F895-903
references: 19656915
references: Ann Intern Med. 2004 Jan 6;140(1):9-17
references: 14706967
references: Int J Cardiol. 2009 Jul 24;136(1):4-16
references: 18774613
references: Ren Fail. 2010;32(9):1031-5
references: 20863205
references: Am J Clin Nutr. 1998 Jul;68(1):52-9
references: 9665096
references: J Am Coll Cardiol. 2006 Aug 1;48(3):478-84
references: 16875972
references: J Am Soc Nephrol. 2009 Dec;20(12):2631-9
references: 19875805
references: Lancet. 1999 Aug 7;354(9177):447-55
references: 10465168
references: J Ren Nutr. 2012 Nov;22(6):572-7
references: 22285316
references: Ren Fail. 2011;33(2):184-91
references: 21332341
references: J Gen Intern Med. 2004 Oct;19(10):1045-52
references: 15482558
references: J Lipid Res. 2005 Feb;46(2):269-80
references: 15576848
references: Circulation. 2002 Nov 19;106(21):2747-57
references: 12438303
references: Am J Clin Nutr. 1975 Sep;28(9):958-66
references: 1163480
references: Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3542-6
references: 8622972
references: Nat Rev Immunol. 2008 May;8(5):349-61
references: 18437155
references: Kidney Int. 2005 Jan;67(1):248-58
references: 15610248
references: Lancet. 1989 Sep 30;2(8666):757-61
references: 2571009
references: Hypertension. 1998 Dec;32(6):1003-10
references: 9856964
references: Proc Nutr Soc. 2010 Aug;69(3):316-23
references: 20509981
references: J Am Soc Nephrol. 1999 Oct;10(10):2177-84
references: 10505695
references: Circulation. 2008 Jan 29;117(4):503-11
references: 18180395
references: J Am Soc Nephrol. 1999 Dec;10(12):2465-73
references: 10589683
references: PLoS One. 2009;4(5):e5444
references: 19421317
references: Endocrine. 2009 Feb;35(1):11-7
references: 18979202
references: Br J Nutr. 2012 Jun;107 Suppl 2:S159-70
references: 22591890
references: Nephrol Dial Transplant. 2000 Jul;15(7):953-60
references: 10862630
references: Nutr Res. 2012 Jul;32(7):495-502
references: 22901557
references: Hypertens Res. 2005 Aug;28(8):651-5
references: 16392769
references: JAMA. 2002 Apr 10;287(14):1815-21
references: 11939867
references: Lancet. 2008 Jan 12;371(9607):117-25
references: 18191683